Allopurinol Rx more likely with eligibility at diagnosis

Allopurinol rx more likely with eligibility at diagnosis

(HealthDay)—Allopurinol prescribing is more likely if patients meet eligibility criteria at diagnosis, according to a research brief published in the November/December issue of the Annals of Family Medicine.

Lorna E. Clarson, Ph.D., from Keele University in the United Kingdom, and colleagues reviewed for 8,142 patients with gout in order to investigate the effect of age, sex, comorbidities, number of consultations, and meeting internationally agreed eligibility criteria on time to allopurinol initiation.

Initiation of allopurinol was positively associated with meeting eligibility criteria at diagnosis of gout, according to the researchers; however, it was negatively associated with becoming eligible after diagnosis.

"Our findings suggest that more frequent chronic disease reviews to revisit patient preferences and eligibility for allopurinol may reduce barriers to successful treatment of gout," the authors write. "Further research should focus on understanding patient and prescriber preferences in allopurinol prescribing and why patients who become eligible for after diagnosis do not receive it."


Explore further

Allopurinol has little benefit in cardiac syndrome X

More information: Abstract
Full Text
Journal information: Annals of Family Medicine

Copyright © 2017 HealthDay. All rights reserved.

Citation: Allopurinol Rx more likely with eligibility at diagnosis (2017, December 12) retrieved 20 September 2019 from https://medicalxpress.com/news/2017-12-allopurinol-rx-eligibility-diagnosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more